Low doses of acetaminophen produce antidepressive-like effects through the opioid system in mice

Behav Brain Res. 2024 Jul 9:469:115065. doi: 10.1016/j.bbr.2024.115065. Epub 2024 May 21.

Abstract

Acetaminophen (paracetamol) is one of the most popular analgesics for the management of fever and pain but few reports have investigated its antidepressant-like effect. Moreover, the role of the opioidergic pathway has been indicated in depression pathophysiology. This study aimed to examine the involvement of the opioid receptors in the antidepressant-like effect of acetaminophen after acute and sub-chronic administration using mice forced swimming test (FST). Our finding showed that administration of acetaminophen (50 and 100 mg/kg, i.p.) 30 min before the FST produced an antidepressant effect which was reduced by naloxone (1 mg/kg, i.p., a nonselective opioid receptor antagonist). Moreover, we observed that acetaminophen in higher doses (200 and 400 mg/kg) was ineffective. Also, the response of the non-effective dose of acetaminophen (25 mg/kg) was potentiated by the non-effective dose of morphine (0.1 mg/kg) in the FST that was antagonized by naloxone. Also, in contrast to morphine (10 mg/kg), acetaminophen (100 mg/kg, i.p.) induced neither tolerance to the anti-immobility behavior nor withdrawal syndrome after repeated administration. In addition, RT-PCR showed that hippocampal mu- and kappa-opioid receptor mRNA expression increased in mice after repeated administration of acetaminophen; however, morphine therapy for 6 days did not affect kappa-opioid receptor expression. Our findings demonstrated that acetaminophen in lower doses but not high doses revealed an antidepressant-like activity without inducing tolerance and withdrawal syndromes. Moreover, the observed effect of acetaminophen may be via altering the opioid system, particularly hippocampal mu- and kappa-receptors.

Keywords: Acetaminophen; Depression; Mu- and kappa-opioid receptors; Tolerance; Withdrawal signs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen* / administration & dosage
  • Acetaminophen* / pharmacology
  • Analgesics, Non-Narcotic / administration & dosage
  • Analgesics, Non-Narcotic / pharmacology
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / pharmacology
  • Animals
  • Antidepressive Agents* / administration & dosage
  • Antidepressive Agents* / pharmacology
  • Depression / drug therapy
  • Depression / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Male
  • Mice
  • Morphine / administration & dosage
  • Morphine / pharmacology
  • Naloxone* / pharmacology
  • Narcotic Antagonists* / administration & dosage
  • Narcotic Antagonists* / pharmacology
  • Receptors, Opioid / drug effects
  • Receptors, Opioid / metabolism
  • Receptors, Opioid, mu / drug effects
  • Receptors, Opioid, mu / metabolism
  • Swimming

Substances

  • Acetaminophen
  • Antidepressive Agents
  • Naloxone
  • Narcotic Antagonists
  • Morphine
  • Analgesics, Opioid
  • Analgesics, Non-Narcotic
  • Receptors, Opioid
  • Receptors, Opioid, mu